Forecast

There is no analyst data available for this company.

News Go to news feed

Alcidion reports record 2026 and forecasts growth for 2027 — shares rise 8%

Alcidion recorded a 27% revenue increase in fiscal 2026 to AUD 51.6m, an ARR of AUD 38.3m (+34%) and a record total contract value of AUD 78.5m. The company generated positive operating cash flow (AUD 6.8m), finished the year debt-free with AUD 20.6m in cash and reported an adjusted EBITDA of AUD 6.8m. Shares rose about 8% after the results, as management expects both revenue and adjusted EBITDA in 2027 to exceed 2026 levels and already cites sold/renewed revenue of AUD 44.9m. Risks remain the timing of large contract wins, margin pressure on capital licences and competitive pressure in the UK. » More on de.investing.com
Alcidion achieves best Q1 in two years with $8.2m in new contracts

In Q1 2025 Alcidion reported its strongest performance in two years with $8.2m in new contracts. Operating cash outflow fell sharply from $4m to $600,000, the cash balance is $16.4m and the company is debt-free. Contracted revenue for 2026 stands at $36.3m, and Alcidion confirms guidance for positive EBITDA and operating cash flow. Management is examining market entries in Saudi Arabia and Canada for international expansion; the share last fell 1.05% to $0.094. » More on de.investing.com
Alcidion benefits from strong cash flow and order growth in Q4 2025

Alcidion recorded a record increase in new orders and positive operating cash flow in the fourth quarter of 2025, which drove the share price up by 12.5%. The company is well positioned for further growth with $17.7 million in liquidity and no debt, and expects EBITDA of over $4.5 million for fiscal year 2025. Risks include potential delays in implementations and challenges in expanding into new markets. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2022, ALCIDION GROUP LTD has already paid €0.0717 in dividends. The last payout was in July 2022.

Financials

In the last quarter, ALCIDION GROUP LTD had revenue of €15.85M and net profit of €578.38K

(EUR)	Jun 2026	YoY
Revenue	15.85M	-
Gross profit	2.46M	-
Net profit	578.38K	-
EBITDA	212.58K	-

Fundamentals

Metric	Value
Market capitalization	€80.39M
Number of shares	1.34B
52-week high/low	€0.0894 - €0.0506
Dividends	No
Beta	1.07
P/E ratio	57.06
PEG ratio	1.37
P/B ratio	1.43
P/S ratio	2.52

Company profile

Die Alcidion Group Limited ist zusammen mit ihren Tochtergesellschaften in der Entwicklung und Lizenzierung von Softwareprodukten für das Gesundheitswesen in Australien, Neuseeland und dem Vereinigten Königreich tätig. Das Unternehmen bietet Miya Precision, eine konsolidierte, auf FHIR (Fast Healthcare Interoperability Resource) basierende Plattform zur Bereitstellung einer intelligenten Gesundheitsversorgung, Smartpage, ein Smartphone- und webbasiertes System für die Krankenhauskommunikation und das Aufgabenmanagement, das den Anforderungen klinischer und nichtklinischer Nutzer gerecht wird, Patientrack, eine Lösung für die Patientenüberwachung und das Risikoscreening in Echtzeit, und ExtraMed, eine Software für das Patientenflussmanagement. Darüber hinaus bietet das Unternehmen Dienstleistungen in den Bereichen Produktimplementierung, Produktunterstützung und -wartung, Systemintegration und Datenanalyse an. Das Unternehmen war früher als Alcidion Corporation Pty Ltd bekannt und änderte im Dezember 2015 seinen Namen in Alcidion Group Limited. Die Alcidion Group Limited wurde im Jahr 2000 gegründet und hat ihren Hauptsitz in South Yarra, Australien.